Thomas Moritz

4.0k total citations
90 papers, 2.8k citations indexed

About

Thomas Moritz is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Thomas Moritz has authored 90 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 21 papers in Genetics and 19 papers in Oncology. Recurrent topics in Thomas Moritz's work include CRISPR and Genetic Engineering (20 papers), Virus-based gene therapy research (17 papers) and Pluripotent Stem Cells Research (14 papers). Thomas Moritz is often cited by papers focused on CRISPR and Genetic Engineering (20 papers), Virus-based gene therapy research (17 papers) and Pluripotent Stem Cells Research (14 papers). Thomas Moritz collaborates with scholars based in Germany, United States and United Kingdom. Thomas Moritz's co-authors include Nico Lachmann, Axel Schambach, Mania Ackermann, Helmut Wagentristl, Sabine Baumgartner, J. Vollmann, W. Widdra, Tobias Cantz, Nils Pfaff and N. Niederle and has published in prestigious journals such as Nature, Physical Review Letters and Nucleic Acids Research.

In The Last Decade

Thomas Moritz

86 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Moritz Germany	27	1.1k	649	423	377	370	90	2.8k
Ming Guan China	37	2.0k 1.8×	486 0.7×	529 1.3×	234 0.6×	403 1.1×	189	4.0k
Kazuyuki Murase Japan	22	928 0.8×	529 0.8×	505 1.2×	138 0.4×	221 0.6×	107	2.4k
Justin P. Annes United States	19	1.6k 1.4×	816 1.3×	514 1.2×	431 1.1×	322 0.9×	46	3.4k
Anita C. Gilliam United States	30	1.5k 1.3×	854 1.3×	423 1.0×	328 0.9×	256 0.7×	66	3.6k
Marian T. Nakada United States	32	1.4k 1.3×	786 1.2×	825 2.0×	251 0.7×	305 0.8×	57	3.5k
Raanan Margalit Israel	30	869 0.8×	914 1.4×	419 1.0×	169 0.4×	170 0.5×	65	3.1k
S. Kanazawa Japan	23	2.0k 1.8×	697 1.1×	584 1.4×	223 0.6×	358 1.0×	105	4.3k
Neil Ashley United Kingdom	21	1.3k 1.2×	393 0.6×	442 1.0×	403 1.1×	105 0.3×	33	2.3k
Paola Spessotto Italy	31	1.1k 1.0×	502 0.8×	734 1.7×	249 0.7×	255 0.7×	85	2.6k

Countries citing papers authored by Thomas Moritz

Since Specialization

Citations

This map shows the geographic impact of Thomas Moritz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Moritz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Moritz more than expected).

Fields of papers citing papers by Thomas Moritz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Moritz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Moritz. The network helps show where Thomas Moritz may publish in the future.

Co-authorship network of co-authors of Thomas Moritz

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Moritz. A scholar is included among the top collaborators of Thomas Moritz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Moritz. Thomas Moritz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ackermann, Mania, Miriam Hetzel, Stephanie Wunderlich, et al.. (2020). Targeted Integration of Inducible Caspase-9 in Human iPSCs Allows Efficient in vitro Clearance of iPSCs and iPSC-Macrophages. International Journal of Molecular Sciences. 21(7). 2481–2481. 13 indexed citations

Manukjan, Georgi, Adele Mucci, Doris Steinemann, et al.. (2020). Forming megakaryocytes from murine induced pluripotent stem cells by the inducible overexpression of supporting factors. Research and Practice in Thrombosis and Haemostasis. 5(1). 111–124. 8 indexed citations

Hoffmann, Dirk, Johannes Kuehle, Daniela Zychlinski, et al.. (2020). Lentiviral gene therapy and vitamin B3 treatment enable granulocytic differentiation of G6PC3-deficient induced pluripotent stem cells. Gene Therapy. 27(6). 297–306. 10 indexed citations

Dannenmann, Benjamin, Maksim Klimiankou, Tatsuya Morishima, et al.. (2019). Human iPSC-based model of severe congenital neutropenia reveals elevated UPR and DNA damage in CD34+ cells preceding leukemic transformation. Experimental Hematology. 71. 51–60. 14 indexed citations

Hetzel, Miriam, Elena López-Rodríguez, Adele Mucci, et al.. (2019). Effective hematopoietic stem cell-based gene therapy in a murine model of hereditary pulmonary alveolar proteinosis. Haematologica. 105(4). 1147–1157. 6 indexed citations

Happle, Christine, Nico Lachmann, Mania Ackermann, et al.. (2018). Pulmonary Transplantation of Human Induced Pluripotent Stem Cell–derived Macrophages Ameliorates Pulmonary Alveolar Proteinosis. American Journal of Respiratory and Critical Care Medicine. 198(3). 350–360. 53 indexed citations

Ackermann, Mania, Henning Kempf, Miriam Hetzel, et al.. (2018). Bioreactor-based mass production of human iPSC-derived macrophages enables immunotherapies against bacterial airway infections. Nature Communications. 9(1). 5088–5088. 111 indexed citations

Volk, Valery, Sebastian J. Theobald, Susanne Rittinghausen, et al.. (2017). Human Effector Memory T Helper Cells Engage with Mouse Macrophages and Cause Graft-versus-Host–Like Pathology in Skin of Humanized Mice Used in a Nonclinical Immunization Study. American Journal Of Pathology. 187(6). 1380–1398. 18 indexed citations

Hoffmann, Dirk, Juliane W. Schott, Franziska K. Geis, et al.. (2017). Detailed comparison of retroviral vectors and promoter configurations for stable and high transgene expression in human induced pluripotent stem cells. Gene Therapy. 24(5). 298–307. 39 indexed citations

10.

Lachmann, Nico, Mania Ackermann, Eileen Frenzel, et al.. (2015). Large-Scale Hematopoietic Differentiation of Human Induced Pluripotent Stem Cells Provides Granulocytes or Macrophages for Cell Replacement Therapies. Stem Cell Reports. 4(2). 282–296. 145 indexed citations

11.

Lachmann, Nico, Sebastian Brennig, Julia Dahlmann, et al.. (2015). Tightly regulated ‘all-in-one’ lentiviral vectors for protection of human hematopoietic cells from anticancer chemotherapy. Gene Therapy. 22(11). 883–892. 7 indexed citations

12.

Suzuki, Takuji, Paritha Arumugam, Takuro Sakagami, et al.. (2014). Pulmonary macrophage transplantation therapy. Nature. 514(7523). 450–454. 235 indexed citations

13.

Giordano, Frank A., Ursula R. Sorg, Nico Lachmann, et al.. (2011). Clonal Inventory Screens Uncover Monoclonality Following Serial Transplantation of MGMT ^P140K -Transduced Stem Cells and Dose-Intense Chemotherapy. Human Gene Therapy. 22(6). 697–710. 14 indexed citations

14.

Lachmann, Nico, Dirk Heckl, Sebastian Brennig, et al.. (2011). MicroRNA-150-regulated vectors allow lymphocyte-sparing transgene expression in hematopoietic gene therapy. Gene Therapy. 19(9). 915–924. 13 indexed citations

15.

McFalls, Edward O., Thomas Moritz, Fred S. Apple, et al.. (2008). Predictors and outcomes of a perioperative myocardial infarction following elective vascular surgery in patients with documented coronary artery disease: results of the CARP trial. European Heart Journal. 29(3). 394–401. 80 indexed citations

16.

Zimering, Mark B., Robert J. Anderson, Ping Luo, & Thomas Moritz. (2008). Plasma basic fibroblast growth factor is correlated with plasminogen activator inhibitor–1 concentration in adults from the Veterans Affairs Diabetes Trial. Metabolism. 57(11). 1563–1569. 6 indexed citations

17.

Dürig, Jan, Peter R. Ebeling, Florian Grabellus, et al.. (2007). A Novel Nonobese Diabetic/Severe Combined Immunodeficient Xenograft Model for Chronic Lymphocytic Leukemia Reflects Important Clinical Characteristics of the Disease. Cancer Research. 67(18). 8653–8661. 49 indexed citations

18.

Kloke, O., N. Niederle, U. Wandl, et al.. (1993). Impact of interferon alpha‐induced cytogenetic improvement on survival in chronic myelogenous leukaemia. British Journal of Haematology. 83(3). 399–403. 51 indexed citations

19.

Moritz, Thomas, O. Kloke, M. Nagel‐Hiemke, et al.. (1992). Tumor necrosis factor α modifies resistance to interferon α in vivo: First clinical data. Cancer Immunology Immunotherapy. 35(5). 342–346. 6 indexed citations

20.

Nagel‐Hiemke, M., Christoph Hiemke, Thomas Moritz, et al.. (1992). Relation between leukocyte counts and cortisol secretion in CML patients undergoing combined TNF α/IFN α therapy. Annals of Hematology. 65(3). 116–120. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact